Health News Releases

  • Today February 17
September 13, 2018 18:25
Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
Boehringer Ingelheim today announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical company specializing in the development of oncolytic viral therapies. ViraTherapeutics dev
September 13, 2018 17:30
OptraSCAN® Receives CE Mark Approval for In-Vitro Diagnostics Use
OptraSCAN®, the leading end-to-end digital pathology solution provider, today announced that their whole-slide scanners have received CE Mark approval for European Standards applicable to “In-Vitro Di
September 13, 2018 10:10
OTEZLA® (Apremilast) Showed Meaningful Improvements in Clinical and Quality-of-Life Measures of Psoriasis Beyond Those Captured by Assessing Skin Alone
Celgene Corporation (NASDAQ:CELG) today announced the results of two post hoc sub-analyses of clinical trials for OTEZLA® (apremilast) at the 27th European Academy of Dermatology and Venereology (EADV
September 10, 2018 22:05
dClinic(DHC) Phase 1 - Over 50% SOLD in first 10 days
“Current Blockchains are not dedicated Healthcare blockchains. They are not purpose built to handle fractal clinical data nor do they pass the scrutiny of worldwide security protocols for clinical dat
September 07, 2018 09:45
Swiss Advanced Vision Launches Harmonis - The First Customizable EDOF IOL for Cataract Surgery
Swiss Advanced Vision (SAV-IOL) has announced the launch of Harmonis, a customizable intraocular lens (IOL) with advanced extended depth of focus (EDOF) optical technology for cataract surgery. For th
September 06, 2018 14:40
JAMA Publishes Greatly Anticipated Phase III Study Using 22nd Century’s SPECTRUM® Very Low Nicotine Content Cigarettes
22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco, announced today that the Journal of the American Medical
September 06, 2018 10:50
New Study Compares Two Methods of Guiding Goal-Directed Fluid Therapy, Noninvasive Masimo PVi® and Invasive Esophageal Doppler
Masimo (NASDAQ: MASI) announced today the findings of a study recently published in BMC Anesthesiology in which researchers at University Hospital Linköping, Sweden, compared the performance of goal-d
September 05, 2018 10:15
Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
Boehringer Ingelheim and Tsinghua University in Beijing announce a collaboration aiming to research and develop immunological therapies for infectious diseases. Scientists will work in the Boehringer
September 03, 2018 13:45
GNT Pharma's Ropesalazine Effective in Treating Dog Dementia
GNT Pharma said Ropesalazine, a drug candidate for Alzheimer’s disease (AD), has shown an outstanding beneficial efficacy in a pilot clinical trial conducted for dogs with cognitive dysfunction syndro
September 03, 2018 11:40
ResMed Files Patent Infringement Action against Fisher & Paykel
ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical device company and innovator in sleep apnea and respiratory care, today filed a petition with the United States International Tra
August 31, 2018 11:55
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading venture capital firms. The funds will support the company’s mission to usher in th
August 31, 2018 10:50
Ferring and Celmatix Launch Ambitious Genomics Collaboration to Advance Care in Reproductive Medicine and Women’s Health
Ferring Pharmaceuticals and Celmatix today announced an ambitious genomics collaboration aimed at uncovering new insights into ovarian biology and accelerating the development of personalized interven
August 28, 2018 14:00
ResMed’s Astral Life Support Ventilator Now Has AutoEPAP in U.S.
ResMed (NYSE: RMD) (ASX: RMD), a global leader in cloud-connected respiratory care devices, today announced key upgrades to its Astral life support ventilators, including Optional AutoEPAP in iVAPS fo
August 28, 2018 11:25
New Study Evaluates the Ability of Masimo ORi™ to Reflect Oxygenation During Moderate Hyperoxia
Masimo (NASDAQ: MASI) announced today the findings of a study recently published in Anesthesia & Analgesia in which researchers at the University of Groningen, the Netherlands, and Ghent University, B
August 27, 2018 16:10
GN Hearing Introduces New Interton Ready™ Hearing Aid with Excellent Connectivity and Personalized Sound at a Compelling Price
GN Hearing, one of the world’s leading hearing aid manufacturers and the pioneer of 2.4 GHz wireless connectivity, today announced the launch of Interton Ready, a next-generation hearing aid, aiming t
August 23, 2018 11:30
22nd Century Receives Order for 3.6 Million SPECTRUM® U.S. Government Research Cigarettes
22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco, announced today that the National Institute on Drug Abuse
August 20, 2018 17:05
Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa® (dabigatran etexilate)
Boehringer Ingelheim today announced that it will present nine sub-analyses from the RE-DUAL PCI™ trial and GLORIA™-AF Registry Program at the upcoming ESC Congress 2018, organised by the European Soc
August 17, 2018 10:45
GN Hearing and Google Announce Partnership to Bring Direct Mobile Streaming from Android Devices to Hearing Aids
GN Hearing and Google have today announced a new technology partnership that will make GN Hearing the first manufacturer to enable a full spectrum of direct audio streaming from Android devices to hea
August 15, 2018 22:05
2018 Healthcare+ Expo Taiwan: Where Tech Meets Medicine
From November 29th to December 2nd 2018, global-leading biomedical and technology institutes will gather in Taipei for the top healthcare and technology event in Asia - The Healthcare+ Expo - Taiwan.
August 14, 2018 11:00
New Study Investigates the Utility of Home Monitoring Using Masimo SET® Pulse Oximetry to Screen Children with Down Syndrome for Risk of Obstructive Sleep Apnea Prior to Diagnostic Multichannel Sleep Studies
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of
Unprecedented Layers of Sound™ and the World’s Most Advanced Rechargeable Hearing Aid Solution
August 14, 2018 09:45
GN Hearing Announces Unprecedented Layers of Sound™ and the World’s Most Advanced Rechargeable Hearing Aid Solution
GN Hearing today unveils the world’s first Premium-Plus hearing aid: ReSound LiNX Quattro™, designed for people who want the very best that technology has to offer and desire a brilliant sound experie
Bob Rhatigan, CEO - Americas (Photo: Business Wire)
August 10, 2018 14:00
Merz Creates Americas Region, Expands Bob Rhatigan’s Leadership Role
Merz, a global leader in medical aesthetics and neurotoxins, today announced the appointment of Bob Rhatigan as Chief Executive Officer - Americas. Expanding on his leadership of Merz’s North American
August 06, 2018 17:40
Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis
Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium (GTC)—consisting of Imperial College London and the Universities of Oxford and Edinburgh—Imperial Innovations, and Oxford BioMedica
August 03, 2018 11:35
Graminex® LLC successfully challenges Serelys’ patents for use of pollen extracts in treating women's PMS and menopausal symptoms
Graminex® LLC is pleased to announce the US Patent Office has rejected Serelys’ patents for use of its pollen extracts in treating women's PMS and menopausal symptoms. In parallel reexamination pro
August 02, 2018 18:50
Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa
Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced recently the launch of the ‘In Reach Africa’ program, an initiative aimed at facilitating quality and innovative hu
25 per page50 per page75 per page100 per page